Aram Huvis, a pioneering South Korean technology company, is transforming the global beauty industry through its innovative AI-powered scalp and skin diagnostic technology. By leveraging extensive data analysis and clinical verification, the company has developed cutting-edge personalized cosmetic solutions that are attracting international attention.
The company's flagship AI Scalp Grader (AISG), recognized as an Innovation Awards Honoree at CES 2023, enables real-time personalized product formulation. With a database of over 100,000 scalp-related records and clinical validation from Seoul National University Bundang Hospital, Aram Huvis has distinguished itself in precision diagnostics.
Global cosmetics giants including LVMH, L'Oréal, and Estée Lauder have already integrated Aram Huvis' technology into their product development strategies. The company's clinical trials demonstrate remarkable efficacy, with a 93% customer satisfaction rate and a 51% reduction in skin risk factors.
Expanding beyond its business-to-business model, Aram Huvis is now entering the consumer market. The company plans to launch personalized brands like Medi Custom and Lilai, targeting specific consumer needs such as healthcare worker hand care and scalp treatment.
With exports to 70 countries and ongoing negotiations in markets like India, Israel, Portugal, and Qatar, Aram Huvis is positioning itself as a global leader in personalized beauty technology. The company's commitment to research and development, investing 18.92% of revenue compared to the national corporate average of 2.89%, underscores its innovative approach.
By offering preservative-free, naturally derived products and utilizing advanced AI diagnostics, Aram Huvis is not just selling cosmetics but providing personalized healthcare solutions that could reshape consumer expectations in the beauty industry.
